MedPath
TGA Approval

MOXIFLOXACIN KABI moxifloxacin (as hydrochloride) 400mg/250mL intravenous infusion injection bottle (241253)

241253

MOXIFLOXACIN KABI moxifloxacin (as hydrochloride) 400mg/250mL intravenous infusion injection bottle

Fresenius Kabi Australia Pty Ltd

May 9, 2016

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/7160fa7ae0a7d17261e23199a4318fc2.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/881f4fb8e3452b29376311c17d24a5fb.pdf

Active Ingredients

moxifloxacin hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOXIFLOXACIN KABI moxifloxacin (as hydrochloride) 400mg/250mL intravenous infusion injection bottle (241253) - TGA 批准文号 | MedPath